Usability of magnetic resonance images acquired at a novel low-field 0.55 T scanner for brain radiotherapy treatment planning

Johanna Grigo(Friedrich-Alexander-Universität Erlangen-Nürnberg), Christoph Bert(Friedrich-Alexander-Universität Erlangen-Nürnberg), Annika Oleszczuk(Friedrich-Alexander-Universität Erlangen-Nürnberg), Rainer Fietkau(Friedrich-Alexander-Universität Erlangen-Nürnberg), Siti Masitho(Friedrich-Alexander-Universität Erlangen-Nürnberg), Hans‐Peter Fautz(Universitätsklinikum Erlangen), Michael Uder(SUNY Upstate Medical University), Miriam Schonath(Friedrich-Alexander-Universität Erlangen-Nürnberg), Raphaela Voigt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Rafael Heiß(Friedrich-Alexander-Universität Erlangen-Nürnberg), Florian Putz(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Physics and Imaging in Radiation Oncology
January 1, 2023
10.1016/j.phro.2023.100412
Cited by 15

Related Papers

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|369
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
|European Urology|2021|298
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O<sup>6</sup>-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
|Journal of Clinical Oncology|2016|197